A class of drugs that inhibits breast cancer progression when used with hormonal therapy might also boost the effectiveness of immune therapy in cases of recurrent, metastatic breast cancer, according to a new study led by ...
May 10, 2021
0
38
Cancerous tumors thrive on blood, extending their roots deep into the fabric of the tissue of their host. They alter the genetics of surrounding cells and evolve to avoid the protective attacks of immune cells. Now, Penn ...
May 3, 2021
0
73
The hormone prolactin has long been understood to play a vital role in breast growth and development and the production of milk during pregnancy. But a pair of recent studies conducted at VCU Massey Cancer Center finds strong ...
Apr 27, 2021
0
19
A unique antibody drug conjugate (ADC), which delivers a high dose of a cancer-killing drug to tumor cells through a targeted antibody, has been found in a global phase 3 clinical study to nearly double the survival time ...
Apr 21, 2021
0
79
Two studies led by Baylor College of Medicine shed new light on the unanswered question of why estrogen receptor-positive (ER+) breast cancer sometimes grows back in the bone and spreads to other tissues despite effective ...
Apr 19, 2021
0
81
New research led by the Garvan Institute of Medical Research has revealed how breast cancer cells that develop during or after pregnancy change their environment to form more aggressive tumors.
Apr 13, 2021
0
42
Exercise training may slow tumor growth and improve outcomes for females with breast cancer—especially those treated with immunotherapy drugs—by stimulating naturally occurring immune mechanisms, researchers at Massachusetts ...
Apr 12, 2021
0
91
Many cancers hijack a metabolic mechanism known as the mTOR pathway to fuel growth and proliferation, and inhibiting that pathway could slow tumor growth, according to a Northwestern Medicine study published in Molecular ...
Apr 8, 2021
0
57
New research from the UVA Cancer Center could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon and triple-negative breast cancer, that ultimately failed in human clinical trials.
Apr 6, 2021
0
111
Researchers in Italy have identified a pair of microRNA molecules that help maintain a population of cancerous stem cells that drive the growth of breast cancers and initiate tumor relapse after treatment. The study, which ...
Apr 2, 2021
0
4
